News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
739,418 Results
Type
Article (53312)
Company Profile (666)
Press Release (685440)
Section
Business (211829)
Career Advice (3381)
Deals (37627)
Drug Delivery (119)
Drug Development (85150)
Employer Resources (183)
FDA (17128)
Job Trends (16236)
News (362043)
Policy (34873)
Tag
Academia (2788)
Alliances (52070)
Alzheimer's disease (1407)
Approvals (17080)
Artificial intelligence (224)
Bankruptcy (383)
Best Places to Work (12287)
Biotechnology (460)
Breast cancer (241)
Cancer (1827)
Cardiovascular disease (143)
Career advice (2851)
CAR-T (140)
Cell therapy (400)
Clinical research (68310)
Collaboration (718)
Compensation (377)
COVID-19 (2768)
C-suite (175)
Data (1666)
Diabetes (230)
Diagnostics (6696)
Earnings (85050)
Employer resources (158)
Events (121024)
Executive appointments (596)
FDA (18058)
Funding (642)
Gene therapy (283)
GLP-1 (757)
Government (4706)
Healthcare (19892)
Infectious disease (2886)
Inflammatory bowel disease (135)
Interviews (661)
IPO (17413)
Job creations (4469)
Job search strategy (2337)
Layoffs (513)
Legal (8438)
Lung cancer (273)
Manufacturing (265)
Medical device (14242)
Medtech (14247)
Mergers & acquisitions (20593)
Metabolic disorders (618)
Neuroscience (1856)
NextGen: Class of 2025 (7259)
Non-profit (4588)
Northern California (2144)
Obesity (347)
Opinion (258)
Patents (170)
People (60574)
Phase I (21341)
Phase II (30091)
Phase III (22581)
Pipeline (740)
Postmarket research (2571)
Preclinical (9019)
Radiopharmaceuticals (263)
Rare diseases (360)
Real estate (6541)
Regulatory (23592)
Research institute (2495)
Resumes & cover letters (537)
Southern California (1844)
Startups (4048)
United States (19570)
Vaccines (704)
Weight loss (257)
Date
Last 7 days (634)
Last 30 days (2635)
Last 365 days (36680)
2025 (4742)
2024 (37582)
2023 (42222)
2022 (53486)
2021 (58085)
2020 (56547)
2019 (49424)
2018 (37605)
2017 (35530)
2016 (35461)
2015 (41215)
2014 (34317)
2013 (29007)
2012 (30655)
2011 (31031)
2010 (28796)
Location
Africa (984)
Arizona (192)
Asia (45231)
Australia (7549)
California (5000)
Canada (1747)
China (419)
Colorado (229)
Connecticut (251)
Europe (98681)
Florida (710)
Georgia (175)
Illinois (513)
Indiana (279)
Maryland (761)
Massachusetts (3903)
Michigan (218)
Minnesota (358)
New Jersey (1413)
New York (1416)
North Carolina (971)
Northern California (2144)
Ohio (182)
Pennsylvania (1125)
South America (1363)
Southern California (1844)
Texas (742)
Utah (151)
Washington State (509)
739,418 Results for "the native antigen company ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
The Chimeric Antigen Receptor (CAR) T-Cell Therapy markets to reach US$ 12,482.2 Million by 2035, exhibiting, Impelled by Technological Advancements in CAR-T Therapy
Chimeric Antigen Receptor (CAR) T-Cell Therapy Market Outlook 2025-2035:
February 17, 2025
·
13 min read
Cancer
Merck and Epitopea Join Forces to Identify Unknown Tumor Antigens
The agreement, in which Merck will pay the biotech an undisclosed initial sum to license drugs targeting a solid tumor, could net Epitopea up to $300 million down the line.
February 19, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
CovarsaDx® Research Team Provides Key Support for the FDA 510(k) Clearance for OSANG Healthcare’s Over-The-Counter QuickFinder™ COVID-19/Flu Antigen Self-Test and QuickFinder™ COVID-19/Flu Antigen Pro Test
January 21, 2025
·
3 min read
The Native Antigen Company Introduces New Range of Influenza Antigens
The Native Antigen Company (part of LGC Clinical Diagnostics) today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season.
November 18, 2022
·
2 min read
Press Releases
Epitopea Announces License and Research Collaboration Agreement with MSD to Identify Cryptigen™ Tumor-Specific Antigens
February 20, 2025
·
3 min read
The Native Antigen Company Expands Infectious Disease Portfolio to Include Sudan Ebolavirus Boniface 1976 Glycoprotein
The Native Antigen Company announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein.
December 8, 2022
·
2 min read
Press Releases
Research by City of Hope and Other Scientists May Help Patients Overcome Resistance to Chimeric Antigen Receptor (CAR) T Cell Therapy
December 24, 2024
·
5 min read
Business
The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio
The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, announced two key appointments to its management team.
November 23, 2022
·
3 min read
TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market Detailed Analysis and Forecast 2024-2031
Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market- (By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others)),
May 24, 2024
·
1 min read
Press Releases
Interius BioTherapeutics Doses First Patient with in vivo Chimeric Antigen Receptor (CAR) Gene Therapy for B-cell Malignancies
October 23, 2024
·
3 min read
1 of 73,942
Next
